Luis Rueda Carrillo
Neurology · Saint Louis, MONPI 1992374086
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by UCB, Inc. at 41.9% of the total. Reporting peaked in 2024 at $692 and has fallen 80.4% since, to $136 in 2025.
Across 71 payments — averaging $24.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$731
- AbbVie$215
- SK Life Science, Inc.$174
- AstraZeneca$78
- Neurelis, Inc.$61
- Chiesi USA, Inc.$58
- plus $428 from 14 others
What the payments were for
- Food & beverage$1,744100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 30 | $731 |
| AbbVie(2 entities) | 5 | $215 |
| SK Life Science, Inc. | 7 | $174 |
| AstraZeneca | 4 | $78 |
| Neurelis, Inc. | 3 | $61 |
| Chiesi USA, Inc. | 3 | $58 |
| Jazz Pharmaceuticals Inc. | 3 | $56 |
| Amylyx Pharmaceuticals, Inc. | 2 | $56 |
| Novartis | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 2 | $35 |
| Lundbeck LLC | 1 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $30 |
| Biogen | 1 | $29 |
| EMD Serono, Inc. | 1 | $29 |
| Amgen | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Immedica Pharma US, Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Novocure Inc. | 1 | $14 |
| Livanova USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$125
How this compares
$1,744 in reported general payments places this provider in the 55th percentile of 381 neurology providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 12 | $12,035 |
| Atorvastatin Calcium | 13 | $229 |
Paid to pharmacies, not to this prescriber.
Other neurology in Saint Louis
- Barry SingerSaint Louis$1.9M
- Mark TullmanSaint Louis$1.5M
- Robert NaismithSaint Louis$677K
- Arun VaradhacharySaint Louis$273K
- Anne CrossSaint Louis$190K
- David HoltzmanSaint Louis$165K
- Ghazala HayatSaint Louis$155K
- Pratap ChandSaint Louis$139K
- Lee TempelSaint Louis$121K
- Salim ChahinSaint Louis$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.